Schedule 13G ownership disclosure
SORRENTO THERAPEUTICS IN
Security class unavailable · CUSIP: 83587F202
Event date: 2017-12-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-035389
- Form type
- SC 13G
- Filer
- Sorrento Therapeutics, Inc.
- CIK
- CIK 850261
- Filed
- Jun 22, 2018
- Reporting period
- Dec 21, 2017
- Description
- Schedule 13G beneficial ownership